Revisiting STAT3 signalling in cancer: new and unexpected biological functions.

Articles citing Revisiting STAT3 signalling in cancer: new and unexpected biological functions.

Title / Author	Year
Macrophages and therapeutic resistance in cancer B Ruffell, LM Coussens Cancer cell 27 (4), 462-472	2015
Therapeutic cancer vaccines CJM Melief, T van Hall, R Arens, F Ossendorp, SH van der Burg The Journal of clinical investigation 125 (9), 3401-3412	2015
Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses Y Lavin, S Kobayashi, A Leader, ED Amir, N Elefant, C Bigenwald, ... Cell 169 (4), 750-765. e17	2017
Suppression of cancer relapse and metastasis by inhibiting cancer stemness Y Li, HA Rogoff, S Keates, Y Gao, S Murikipudi, K Mikule, D Leggett, W Li, ... Proceedings of the National Academy of Sciences 112 (6), 1839-1844	2015
CD45 phosphatase inhibits STAT3 transcription factor activity in myeloid cells and promotes tumor-associated macrophage differentiation V Kumar, P Cheng, T Condamine, S Mony, LR Languino, JC McCaffrey, ... Immunity 44 (2), 303-315	2016
Hepcidin: regulation of the master iron regulator G Rishi, DF Wallace, VN Subramaniam Bioscience reports 35 (3), e00192	2015
The clinical relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 network in chemoresistant non-small-cell lung cancer Y Fujita, S Yagishita, K Hagiwara, Y Yoshioka, N Kosaka, F Takeshita, ... Molecular therapy 23 (4), 717-727	2015
The complex role of neutrophils in tumor angiogenesis and metastasis W Liang, N Ferrara Cancer immunology research 4 (2), 83-91	2016
Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL-6 mediated involvement R Bharti, G Dey, M Mandal Cancer letters 375 (1), 51-61	2016
Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis X Wang, W Sun, W Shen, M Xia, C Chen, D Xiang, B Ning, X Cui, H Li, ... Journal of hepatology 64 (6), 1283-1294	2016
Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets M Klingenberg, A Matsuda, S Diederichs, T Patel Journal of hepatology 67 (3), 603-618	2017
Graphene oxide selectively targets cancer stem cells, across multiple tumor types: implications for non-toxic cancer treatment, via “differentiation-based nano-therapy” M Fiorillo, AF Verre, M Iliut, M Peiris-Pagés, B Ozsvari, R Gandara, ... Oncotarget 6 (6), 3553	2015
Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds MK Shanmugam, JH Lee, EZP Chai, MM Kanchi, S Kar, F Arfuso, ... Seminars in cancer biology 40, 35-47	2016
Iron and cancer: recent insights DH Manz, NL Blanchette, BT Paul, FM Torti, SV Torti Annals of the New York Academy of Sciences 1368 (1), 149	2016
Feedback activation of STAT3 as a cancer drug-resistance mechanism C Zhao, H Li, HJ Lin, S Yang, J Lin, G Liang Trends in pharmacological sciences 37 (1), 47-61	2016
Lung adenocarcinoma distally rewires hepatic circadian homeostasis S Masri, T Papagiannakopoulos, K Kinouchi, Y Liu, M Cervantes, P Baldi, ... Cell 165 (4), 896-909	2016
Long-term culture and expansion of primary human hepatocytes G Levy, D Bomze, S Heinz, SD Ramachandran, A Noerenberg, M Cohen, ... Nature biotechnology 33 (12), 1264	2015
c-Met as a target for personalized therapy I Garajová, E Giovannetti, G Biasco, GJ Peters Translational oncogenomics 7 (Suppl 1), 13	2015
Small cell lung cancer: can recent advances in biology and molecular biology be translated into improved outcomes? PA Bunn, JD Minna, A Augustyn, AF Gazdar, Y Ouadah, MA Krasnow, ... Journal of Thoracic Oncology 11 (4), 453-474	2016
LncSox4 promotes the self-renewal of liver tumour-initiating cells through Stat3-mediated Sox4 expression Z Chen, L Huang, Y Wu, W Zhai, P Zhu, Y Gao Nature communications 7, 12598	2016

1 - 20

Dates and citation counts are estimated and are determined automatically by a computer program.